Basilea Pharmaceutica AG
BPMUF
$77.40
$11.9018.17%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -1.15% | -11.12% | |||
| Total Other Revenue | -1.15% | 8.58% | |||
| Total Revenue | -1.15% | -7.35% | |||
| Cost of Revenue | -1.15% | -16.03% | |||
| Gross Profit | -1.15% | 8.34% | |||
| SG&A Expenses | -1.15% | -1.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.15% | -13.50% | |||
| Operating Income | -1.15% | 14.85% | |||
| Income Before Tax | -1.15% | 21.15% | |||
| Income Tax Expenses | -1.15% | 100.73% | |||
| Earnings from Continuing Operations | -1.15% | 14.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.15% | 14.34% | |||
| EBIT | -1.15% | 14.85% | |||
| EBITDA | -1.15% | 7.68% | |||
| EPS Basic | -1.15% | 13.13% | |||
| Normalized Basic EPS | -1.15% | 20.63% | |||
| EPS Diluted | -1.15% | 12.49% | |||
| Normalized Diluted EPS | -1.16% | 19.36% | |||
| Average Basic Shares Outstanding | 0.00% | 1.06% | |||
| Average Diluted Shares Outstanding | 0.00% | 2.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||